Aptevo Therapeutics Announces Pricing Of $5M Public Offering Of 8,064,517 Shares Of Common Stock At $0.62/ Share
Portfolio Pulse from Benzinga Newsdesk
Aptevo Therapeutics has announced the pricing of its $5M public offering of 8,064,517 shares of common stock at $0.62 per share.
August 04, 2023 | 10:40 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aptevo Therapeutics' public offering of 8,064,517 shares at $0.62 per share could potentially dilute the value of existing shares.
The public offering of new shares by Aptevo Therapeutics could lead to dilution of the value of existing shares. This is because the number of shares in circulation will increase, potentially reducing the earnings per share. This could lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100